“ Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients ”, Clinics, vol. 66, no. 1, pp. 101–106, Jan. 2011, doi: 10.1590/S1807-59322011000100018.